Advertisement
Screener

BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

BLACK DIAMOND THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where BLACK DIAMOND THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $29.61M came in.
  • Fiscal year ended 2025-12-31: from investing, $44.91M went out.
  • Fiscal year ended 2025-12-31: from financing, $146.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $15.44M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31$29.61M-$44.91M$0.00-$15.44M
2024-12-31-$62.30M$16.97M$24.49M$1.05M*-$19.79M
2023-12-31-$66.72M$16.35M$71.85M$21.56M
2022-12-31-$85.08M$53.37M$0.00-$31.54M
2021-12-31-$100.15M$130.61M$729.00K$31.19M
2020-12-31-$52.15M-$281.69M$1.10M$213.84M*-$118.89M
2019-12-31-$24.67M-$21.00K$0.00$127.76M*$103.06M
2018-12-31-$8.45M-$76.00K$52.31M*$43.78M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$7.97M*-$3.12M*
2026-03-31-$10.23M$19.50M$9.08M
2025-12-31-$6.79M*-$2.89M*$0.00*
2025-09-30-$7.85M*$8.59M*$0.00*
2025-06-30-$9.16M*-$59.15M*$0.00*
2025-03-31$53.41M$8.55M$0.00$61.99M
2024-12-31-$15.05M*$27.77M*$0.00*
2024-09-30-$11.32M*$2.19M*-$500.00K*
2024-06-30-$14.73M*$740.00K*$21.01M*
2024-03-31-$21.20M-$13.73M$3.98M-$30.80M
2023-12-31-$13.96M*$12.25M*$0.00*
2023-09-30-$18.36M*-$37.88M*$71.85M*
2023-06-30-$14.37M*$17.18M*$0.00*
2023-03-31-$20.03M$24.81M$0.00$4.83M
2022-12-31-$21.94M*$2.32M*$0.00*
2022-09-30-$16.48M*$14.51M*
2022-06-30-$18.07M*$19.81M*
2022-03-31-$28.60M$16.73M-$11.72M
2021-12-31-$24.05M*$43.24M*
2021-09-30-$26.48M*$35.70M*
2021-06-30-$25.16M*$48.20M*$184.00K*
2021-03-31-$24.45M$3.47M$481.00K-$20.50M
2020-12-31-$15.77M*-$6.65M*$830.00K*
2020-09-30-$11.49M*$4.60M*$270.00K*
2020-06-30-$13.57M*-$279.64M*$0.00*
2020-03-31-$11.32M$0.00$0.00$213.84M*$202.53M
2019-12-31-$7.49M*-$2.00K*$0.00*$83.50M*
2019-09-30-$5.31M*-$11.00K*$44.33M*
2019-06-30-$5.00M*$2.00K*
2019-03-31-$6.88M-$10.00K-$6.89M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Vaxart, Inc. (VXRT)United States$0.080B3.84